Incorporation of pollen data in source maps is vital for pollen dispersion models

Information about distribution of pollen sources, i.e. their presence and abundance in a specific region, is important especially when atmospheric transport models are applied to forecast pollen concentrations. The goal of this study is to evaluate three pollen source maps using an atmospheric transport model and study the effect on the model results by combining these source maps with pollen data. Here we evaluate three maps for the birch taxon: (1) a map derived by combining land cover data and forest inventory; (2) a map obtained from land cover data and calibrated using model simulations and pollen observations; (3) a statistical map resulting from analysis of forest inventory and forest plot data. The maps were introduced to the Enviro-HIRLAM (Environment – High Resolution Limited Area Model) as input data to simulate birch pollen concentrations over Europe for the birch pollen season 2006. 18 model runs were performed using each of the selected maps in turn with and without calibration with observed pollen data from 2006. The model results were compared with the pollen observation data at 12 measurement sites located in Finland, Denmark and Russia.We show that calibration of the maps using pollen observations significantly improved the model performance for all three maps. The findings also indicate the large sensitivity of the model results to the source maps and agree well with other studies on birch showing that pollen or hybrid-based source maps provide the best model performance. This study highlights the importance of including pollen data in the production of source maps for pollen dispersion modelling and for exposure studies

Meta-analysis of clodronate and breast cancer survival

Clinical trials have reported conflicting results on whether oral clodronate therapy improves survival in breast cancer patients. This study was undertaken to evaluate further the effect of oral clodronate therapy on overall survival, bone metastasis-free survival and nonskeletal metastasis-free survival among breast cancer patients. An extensive literature search was undertaken for the period 1966 to July 2006 to identify clinical trials examining survival in breast cancer patients who received 2 or 3 years of oral clodronate therapy at 1600 mg day−1 compared with those without therapy. Meta-analyses were carried out separately for patients diagnosed with advanced breast cancer and early breast cancer. Our meta-analysis found no evidence of any statistically significant difference in overall survival, bone metastasis-free survival or nonskeletal metastasis-free survival in advanced breast cancer patients receiving clodronate therapy or early breast cancer patients receiving adjuvant clodronate treatment compared with those who did not receive any active treatment

Incorporation of pollen data in source maps is vital for pollen dispersion models (Discussion Paper)

Information about distribution of pollen sources, i.e. their presence and abundance in a specific region, is important especially when atmospheric transport models are applied to forecast pollen concentrations. The goal of this study is to evaluate three pollen source maps using an atmospheric transport model and study the effect on the model results by combining these source maps with pollen data. Here we evaluate three maps for the birch taxon: (1) a map derived by combining land cover data and forest inventory; (2) a map obtained from land cover data and calibrated using model simulations and pollen observations; (3) a statistical map resulting from analysis of forest inventory and forest plot data. The maps were introduced to the Enviro-HIRLAM (Environment – High Resolution Limited Area Model) as input data to simulate birch pollen concentrations over Europe for the birch pollen season 2006. 18 model runs were performed using each of the selected maps in turn with and without calibration with observed pollen data from 2006. The model results were compared with the pollen observation data at 12 measurement sites located in Finland, Denmark and Russia.We show that calibration of the maps using pollen observations significantly improved the model performance for all three maps. The findings also indicate the large sensitivity of the model results to the source maps and agree well with other studies on birch showing that pollen or hybrid-based source maps provide the best model performance. This study highlights the importance of including pollen data in the production of source maps for pollen dispersion modelling and for exposure studies

Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas—An EAACI Task Force Report

Background: The effectiveness of allergen immunotherapy (AIT) in seasonal allergic rhinitis (AR) depends on the definition of pollen exposure intensity or time period. We recently evaluated pollen and symptom data from Germany to examine the new definitions of the European Academy of Allergy and Clinical Immunology (EAACI) on pollen season and peak pollen period start and end. Now, we aim to confirm the feasibility of these definitions to properly mirror symptom loads for grass and birch pollen-induced allergic rhinitis in other European geographical areas such as Austria, Finland and France, and therefore their suitability for AIT and clinical practice support. Methods: Data from twenty-three pollen monitoring stations from three countries in Europe and for 3 years (2014-2016) were used to investigate the correlation between birch and grass pollen concentrations during the birch and grass pollen season defined via the EAACI criteria, and total nasal symptom and medication scores as reported with the aid of the patient's hay-fever diary (PHD). In addition, we conducted a statistical analysis, together with a graphical investigation, to reveal correlations and dependencies between the studied parameters. Results: The analysis demonstrated that the definitions of pollen season as well as peak pollen period start and end as proposed by the EAACI are correlated to pollen-induced symptom loads reported by PHD users during birch and grass pollen season. A statistically significant correlation (slightly higher for birch) has been found between the Total Nasal Symptom and Medication Score (TNSMS) and the pollen concentration levels. Moreover, the maximum symptom levels occurred mostly within the peak pollen periods (PPP) following the EAACI criteria. Conclusions: Based on our analyses, we confirm the validity of the EAACI definitions on pollen season for both birch and grass and for a variety of geographical locations for the four European countrie

Health-related Quality of Life of Breast Cancer Survivors Attending an Exercise Intervention Study: A Five-year Follow-up

Background/Aim: As the number of breast cancer survivors is increasing, their long-term health-related quality of life (HRQoL) has become an important issue. The aim of the study is to follow up the HRQoL of breast cancer survivors (BCS) in a prospective randomized exercise intervention study and to compare HRQoL to that of the age-matched general female population. Patients and Methods: Following adjuvant treatment, 537 patients aged 35-68 and capable of exercise training were randomized to a 12-month exercise trial. In 182 of those patients, HRQoL was measured by the generic 15D at baseline and followed up for five years. Furthermore, the HRQoL of all BCS answering the 15D at five-year follow-up (n=390) was compared to that of a representative sample of the general population. Results: After five years, the BCS' mean HRQoL demonstrated a statistically and clinically significant impairment compared to that of the general population (difference -0.023, p<0.001). The mean HRQoL of BCS followed up from baseline until five years did not improve significantly (change=0.007, p=0.27), whereas the dimensions of usual activities (0.043, p=0.004), depression (0.038, p=0.007), distress (0.030, p=0.036), and sexual activity (0.057, p=0.009) did. Conclusion: The HRQoL of BCS was still impaired five years following treatment